NASDAQ:SLGL - Sol Gel Technologies Stock Price, Forecast & News

Sol Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL."

Sol Gel Technologies Ltd (NASDAQ:SLGL) announced its quarterly earnings data on Wednesday, November, 13th. The company reported ($0.37) EPS for the quarter, missing the Zacks' consensus estimate of ($0.25) by $0.12. The business earned $4.73 million during the quarter, compared to analysts' expectations of $6.56 million. Sol Gel Technologies had a negative net margin of 223.99% and a negative return on equity of 71.98%. View Sol Gel Technologies' Earnings History.

Sol Gel Technologies is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for Sol Gel Technologies.

4 equities research analysts have issued 12-month target prices for Sol Gel Technologies' shares. Their forecasts range from $23.00 to $33.00. On average, they anticipate Sol Gel Technologies' stock price to reach $26.50 in the next year. This suggests a possible upside of 101.5% from the stock's current price. View Analyst Price Targets for Sol Gel Technologies.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sol Gel Technologies in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sol Gel Technologies.

Media headlines about SLGL stock have trended negative on Wednesday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Sol Gel Technologies earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an effect on the stock's share price in the next few days. View News Stories for Sol Gel Technologies.

Sol Gel Technologies saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 53,800 shares, an increase of 10.5% from the December 31st total of 48,700 shares. Based on an average trading volume of 82,900 shares, the days-to-cover ratio is presently 0.6 days. Currently, 1.4% of the company's shares are sold short. View Sol Gel Technologies' Current Options Chain.

Some companies that are related to Sol Gel Technologies include Revance Therapeutics (RVNC), XBiotech (XBIT), Odonate Therapeutics (ODT), Akebia Therapeutics (AKBA), Amphastar Pharmaceuticals (AMPH), Applied Therapeutics (APLT), RAPT Therapeutics (RAPT), Gossamer Bio (GOSS), Phathom Pharmaceuticals (PHAT), Radius Health (RDUS), Achillion Pharmaceuticals (ACHN), G1 Therapeutics (GTHX), Aprea Therapeutics (APRE), Dova Pharmaceuticals (DOVA) and Kiniksa Pharmaceuticals (KNSA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sol Gel Technologies investors own include Amarin (AMRN), Iovance Biotherapeutics (IOVA), NVIDIA (NVDA), Applied Optoelectronics (AAOI), Adaptimmune Therapeutics (ADAP), Aqua Metals (AQMS), Arena Pharmaceuticals (ARNA), Inovio Pharmaceuticals (INO), Ligand Pharmaceuticals (LGND) and Mylan (MYL).

(SLGL) raised $60 million in an initial public offering on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. ​Jefferies and BMO Capital Markets​ acted as the underwriters for the IPO and JMP Securities and Raymond James​ were co-managers.

Shares of SLGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SLGL stock can currently be purchased for approximately $13.15.

Sol Gel Technologies has a market capitalization of $248.80 million and generates $130,000.00 in revenue each year. The company earns $-32,200,000.00 in net income (profit) each year or ($1.80) on an earnings per share basis. View Additional Information About Sol Gel Technologies.

The official website for Sol Gel Technologies is http://www.sol-gel.com/.

Sol Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403650. The company can be reached via phone at 972-8931-3429 or via email at [email protected]